Want to join the conversation?
$BIIB and $IONS said $BIIB closed rolling submission of a New Drug Application (NDA) to the FDA for approval of nusinersen, an investigational treatment for spinal muscular atrophy (SMA). $BIIB has also applied for Priority Review which, if granted, would shorten the review period of nusinersen after the Agency's acceptance of the NDA.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?